Therapeutic Advances in Endocrinology and Metabolism

Therapeutic Advances in Endocrinology and Metabolism is a peer-reviewed open access journal published by SAGE since 2010, covering clinical and translational advances across endocrinology and metabolism, with a 2025 Journal Impact Factor of 7.8 and a first quartile rank of 18 of 198 in endocrinology and metabolism.《内分泌学与代谢治疗进展》（Therapeutic Advances in Endocrinology and Metabolism）是（SAGE）自 2010 年起出版的同行评审开放获取期刊，涵盖内分泌学与代谢领域的临床与转化进展，2025 年影响因子为 7.8，在 198 种内分泌与代谢类期刊中列第 18 位，居第一四分位。

Scope

• Diabetes and obesity are the largest clinical areas, covering pharmacological and device-based treatment.糖尿病与肥胖是最大的临床板块，涵盖药物与器械治疗。
• Thyroid disease is covered from diagnosis through long-term management.甲状腺疾病从诊断到长期管理均在范围内。
• Bone and mineral metabolism, including osteoporosis and parathyroid disease, forms a distinct area.骨与矿物质代谢，包括骨质疏松与甲状旁腺疾病，构成独立板块。
• Pituitary and adrenal disorders are addressed with an emphasis on therapeutic decision-making.垂体与肾上腺疾病聚焦治疗决策。
• Lipid disorders and cardiometabolic risk are treated as linked to endocrine practice.脂质紊乱与心血管代谢风险被视为与内分泌实践相关的内容。
• Reproductive and gonadal endocrinology is within the journal's remit.生殖与性腺内分泌属于该刊范围。
• New agents such as glucagon-like peptide 1 receptor agonists receive dedicated review coverage.胰高血糖素样肽 1 受体激动剂等新药获得专门综述。

History

• The journal was launched in 2010 and has been published online by SAGE since then.该刊于 2010 年创办，此后一直由（SAGE）在线出版。
• It is a fully open access title and a member of the Committee on Publication Ethics.该刊为全开放获取期刊，并且是出版伦理委员会成员。
• Articles are published continuously and gathered into one annual volume.文章持续在线发表，按年度汇为一卷。
• Its Journal Impact Factor moved from 3.565 in 2021 to 4.435 in 2022, 4.6 in 2024 and 7.8 in 2025, with a five-year value of 5.9.该刊影响因子由 2021 年的 3.565 升至 2022 年的 4.435，2024 年为 4.6，2025 年为 7.8，五年影响因子为 5.9。
• The acceptance rate is 22.7 percent, with a median of 8 days to first decision and 31 days from acceptance to publication.录用率为 22.7%，首次决定中位时间 8 天，录用到出版 31 天。
• It is indexed in the Science Citation Index Expanded and Scopus.该刊被（Science Citation Index Expanded）与（Scopus）收录。

Editors

• Christoph Schindler of Hannover Medical School in Germany is editor-in-chief.主编（Christoph Schindler）任职于德国（Hannover Medical School）。
• Srikanth Bellary of Aston University in Birmingham is deputy editor-in-chief.副主编（Srikanth Bellary）任职于（Aston University）。
• Thirteen associate editors work in the United States, Spain, Italy, Denmark, the United Kingdom, Japan, Australia and Colombia.13 位副主编分别任职于美国、西班牙、意大利、丹麦、英国、日本、澳大利亚与哥伦比亚。
• An editorial board of about 40 members and a separate editorial review board support peer review across subspecialties.约 40 位成员的编委会与独立的编辑评审委员会共同支持各亚专科的同行评审。
• The journal publishes reviews, original research and case reports, with a preference for work that changes clinical practice.该刊发表综述、原创研究与病例报告，优先考虑能改变临床实践的研究。
• Manuscripts are submitted through the SAGE online system, and peer review takes a median of 68 days.稿件经（SAGE）在线系统投递，同行评审中位时间为 68 天。